Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Robert J. Seager"'
Autor:
Santosh K. Patnaik, MD, PhD, Cara Petrucci, PhD, Joseph Barbi, PhD, Robert J. Seager, PhD, Sarabjot Pabla, PhD, Sai Yendamuri, MD
Publikováno v:
JTO Clinical and Research Reports, Vol 2, Iss 12, Pp 100254- (2021)
Introduction: Statins, used for their lipid-lowering activity, have anti-inflammatory and anticancer properties as well. We evaluated this potential benefit of statin use in patients with NSCLC. Methods: All 613 patients with pathologic stage 1 or 2
Externí odkaz:
https://doaj.org/article/589bd2c2b95241a8bf3e7e8688a886b5
Autor:
Lindsay Nitsche, Yeshwanth Vedire, Eric Kannisto, Xiaolong Wang, Robert J. Seager, Sarabjot Pabla, Santosh K. Patnaik, Sai Yendamuri
Publikováno v:
Cancers; Volume 14; Issue 14; Pages: 3450
While obesity measured by body mass index (BMI) has been paradoxically associated with reduced risk and better outcome for lung cancer, recent studies suggest that the harm of obesity becomes apparent when measured as visceral adiposity. However, the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bb88f0e360191e82e76e5db865b2b204
https://pubmed.ncbi.nlm.nih.gov/35884508
https://pubmed.ncbi.nlm.nih.gov/35884508
Autor:
Sarabjot Pabla, Robert J. Seager, Mary Nesline, Paul DePietro, Erik Van Roey, Shuang Gao, Shakti Ramkissoon, Lei Deng, Shengle Zhang, Roger David Klein, Jeffrey M. Conroy
Publikováno v:
Journal of Clinical Oncology. 40:2623-2623
2623 Background: Immune checkpoint inhibitors (ICIs) have emerged as effective treatments in non-small cell lung cancer (NSCLC). While the clinical utility of single agent ICI or in combination with chemotherapy has been well established, there remai
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::260bc4a948f61a48c4d9a40996590575
https://doi.org/10.1200/jco.2022.40.16_suppl.2623
https://doi.org/10.1200/jco.2022.40.16_suppl.2623